Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...

Early initiation of biologic therapy in patients with Crohn’s disease (CD) is associated with higher rates of transmural healing and leads to improved long-term outcomes. In CD, early initiation of ...

Earlier initiation of biologics in severe asthma could prevent thousands of deaths and save billions in healthcare costs by reducing exacerbations and healthcare resource utilization. Real-world data ...

A discrete choice experiment (DCE) revealed no meaningful difference in preference between dual biologic therapy (DBT) or monotherapy among patients with inflammatory bowel disease (IBD) who had ...

Panelists discuss how biologic therapy selection depends on disease burden rather than just body surface area (BSA), with monitoring requiring objective measures, patient-reported outcomes, and ...

Lead program, MMT-205, licensed from MabTics Co., Ltd / Curacle Co., Ltd. is a potential best-in-class bispecific antibody which activates Tie2 ...

For patients with moderate to severe asthma with uncontrolled disease, add-on biologic maintenance therapy such as dupilumab or tezepelumab may be appropriate. In this article, Amanda Michaud, DMSc, ...

Please provide your email address to receive an email when new articles are posted on . The majority of patients and clinicians agreed with the use of as-needed biologic therapy for psoriasis.

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. We are really fortunate to be managing ...

A clinical trial co-led by the Hospital for Special Surgery (HSS) has found that blocking inflammation with the drug certolizumab significantly reduces the risk of serious adverse pregnancy outcomes ...

HCW Biologics Inc. HCWB stock fell during Tuesday’s session. The company announced preliminary results from its Phase 1 trial ...

Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced positive findings from updated analyses of ...